Clinical and microbiological efficacy and toxicity of colistin in patients infected with multidrug-resistant gram-negative pathogens

Autor: Yılmaz, Gül R., Baştuğ, Aliye Tanrıcı, But, Ayşe, Yıldız, Sümeyye, Yetkin, M.Arzu, Kanyılmaz, Dilek, Akıncı, Esragül, Bodur, Hürrem

Publikováno v: In Journal of Infection and Chemotherapy 2013 19(1):57-62

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and ⁹⁰ Y-DOTA.

Autor: Orozco JJ; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington. jorozco@fhcrc.org.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Kenoyer AL; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Lin Y; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., O'Steen S; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Guel R; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Nartea ME; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Hernandez AH; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Hylarides MD; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington., Fisher DR; Versant Medical Physics and Radiation Dosimetry, Richland, Washington., Balkin ER; Department of Radiation Oncology, University of Washington, Seattle, Washington., Hamlin DK; Department of Radiation Oncology, University of Washington, Seattle, Washington., Wilbur DS; Department of Radiation Oncology, University of Washington, Seattle, Washington., Orcutt KD; Invicro, LLC, Boston, Massachusetts., Wittrup KD; Massachusetts Institute of Technology, Boston, Massachusetts., Green DJ; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Gopal AK; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Till BG; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Sandmaier B; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Press OW; Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington., Pagel JM; Swedish Cancer Institute, Seattle, Washington.

Publikováno v: Molecular cancer therapeutics [Mol Cancer Ther] 2020 Dec; Vol. 19 (12), pp. 2575-2584. Date of Electronic Publication: 2020 Oct 20.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.